Darae Kim
Overview
Explore the profile of Darae Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Kim Y, Kim D, Choi J, Choi K, Hahn J, et al.
JACC Cardiovasc Interv
. 2025 Mar;
PMID: 40047753
No abstract available.
2.
Hong D, Hong M, Kim O, Shin H, Bak M, Kim D, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Mar;
PMID: 40043944
Introduction And Objectives: This study aimed to evaluate the efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors throughout the spectrum of kidney function in patients with heart failure (HF)....
3.
Choi K, Kang D, Lee S, Kim D, Cho S, Choi S, et al.
BMC Med
. 2025 Feb;
23(1):130.
PMID: 40022101
Background: The relationship between coronary artery calcium (CAC) and progression of diastolic dysfunction (DD) during longitudinal follow-up is uncertain. This study aimed to investigate the prevalence and progression of DD...
4.
Ha J, Lee S, Choi K, Shin D, Hong D, Kim D, et al.
JACC Cardiovasc Interv
. 2025 Feb;
18(4):439-452.
PMID: 40010915
Background: Impaired microcirculatory function after heart transplantation is associated with increased risk for acute cellular rejection. Microvascular resistance reserve (MRR) is a novel index for assessing microcirculatory function, irrespective of...
5.
Hyun J, Youn J, Hong J, Kim D, Kim J, Kim M, et al.
J Korean Med Sci
. 2025 Jan;
40(3):e14.
PMID: 39834223
Background: Shortage of organ donors in the Republic of Korea has become a major problem. To address this, it has been questioned whether heart transplant (HTx) allocation should be modified...
6.
Jeon K, Jang S, Lee Y, Kim J, Kim D, Chang S, et al.
J Cardiovasc Imaging
. 2025 Jan;
33(1):1.
PMID: 39806504
Background: There are insufficient studies to determine whether sodium-glucose cotransporter type 2 inhibitors (SGLT2i) will help reduce early diabetic cardiomyopathy, especially in patients without documented cardiovascular disease. Methods: We performed...
7.
Bak M, Chi S, Jeon K, Hong D, Shin H, Kim D, et al.
Sci Rep
. 2024 Dec;
14(1):30653.
PMID: 39730335
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the only medications that improve clinical outcomes regardless of baseline left ventricular ejection fraction. Despite the recognized effectiveness of SGLT-2 inhibitors, there remains a...
8.
Kim S, Yang J, Lee K, Jeon J, Yoon S, Kim D, et al.
Kidney Res Clin Pract
. 2024 Dec;
PMID: 39639416
Background: Light chain amyloidosis, characterized by amyloid fibril deposition in multiple organs, often leads to progression to endstage kidney disease. This study aimed to identify predictors of kidney survival in...
9.
Choi H, Lee S, Hyun J, Kim D, Choi D, Jeon E, et al.
Korean Circ J
. 2024 Oct;
55(2):79-96.
PMID: 39434361
Background And Objectives: The Korean Organ Transplant Registry (KOTRY) provided data for this third official report on adult heart transplantation (HT), including information from 709 recipients. Methods: Data from HTs...
10.
Jeon H, Jeon J, Lee K, Kim J, Kim D, Lee J, et al.
Ren Fail
. 2024 Sep;
46(2):2401623.
PMID: 39313766
Background: Diastolic dysfunction with left ventricular hypertrophy and myocardial fibrosis is an important characteristic of uremic cardiomyopathy in end-stage kidney disease (ESKD). Few studies explored the relationship between changes in...